Elevation Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.67M Sell
6,325
-23
-0.4% -$6.07K 0.47% 38
2026
Q2
$1.61M Buy
6,348
+3,443
+119% +$802K 0.48% 39
2026
Q1
$710K Sell
2,905
-136
-4% -$31.7K 0.25% 56
2025
Q4
$629K Sell
3,041
-657
-18% -$130K 0.22% 62
2025
Q3
$686K Sell
3,698
-328
-8% -$56.2K 0.25% 58
2025
Q2
$615K Sell
4,026
-412
-9% -$63.3K 0.24% 59
2025
Q1
$736K Sell
4,438
-183
-4% -$28.6K 0.32% 51
2024
Q4
$668K Sell
4,621
-396
-8% -$61.4K 0.28% 51
2024
Q3
$813K Sell
5,017
-222
-4% -$35.4K 0.35% 47
2024
Q2
$766K Sell
5,239
-245
-4% -$36.4K 0.36% 48
2024
Q1
$868K Sell
5,484
-1,548
-22% -$246K 0.43% 45
2023
Q4
$1.1M Buy
7,032
+6,233
+780% +$956K 0.66% 31
2023
Q3
$124K Buy
799
+4
+0.5% +$660 0.11% 79
2023
Q2
$132K Hold
795
– – 0.11% 81
2023
Q1
$123K Buy
+795
New +$128K 0.11% 86

Other funds holding JNJ

Elevation Wealth Partners's JNJ Position: Q3 2026 in Review

Elevation Wealth Partners reduced its Johnson & Johnson (JNJ) stake by 0.36% in Q3 2026, selling an estimated $6.07K and leaving 6,325 shares worth $1.67M. The position accounts for 0.47% of the portfolio, ranked #38.

Elevation Wealth Partners first reported a position in JNJ in Q1 2023 and has held it in 15 quarters since. 1,846 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Elevation Wealth Partners held 6,325 shares of Johnson & Johnson worth $1.67M as of Q3 2026.
  • Elevation Wealth Partners sold 23 Johnson & Johnson shares in Q3 2026, an estimated $6.07K.
  • Johnson & Johnson made up 0.47% of Elevation Wealth Partners's portfolio in Q3 2026, its #38 holding.
  • Elevation Wealth Partners first reported a position in Johnson & Johnson in Q1 2023 and has held it in 15 quarters since.
  • 1,846 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.